A recent study highlights robust public support for tighter marijuana regulations in Canada, with calls for stronger policies to prioritise public welfare. Published in the American Journal of Drug and Alcohol Abuse, the research, based on data from the International Cannabis Policy Study, underscores a clear divide between general public opinion and the views of cannabis...
Category: Policy Updates
North Carolina Hemp Regulation Faces Major Overhaul
Hemp-derived products have become big business in North Carolina. The state has earned a reputation as one of the most lenient when it comes to regulating psychoactive hemp products. Dispensaries, bars, and even pizza shops across North Carolina can legally sell hemp-based goods—even those producing a recreational high. However, new legislation may soon bring big...
Cannabis Legalisation in France: Why The Academy of Medicine Stands Firmly Against It
The debate around cannabis legalisation in France remains a contentious issue, with growing public and political interest. Among the voices opposing this shift is the French Academy of Medicine, which has reinforced its steadfast stance against the legalisation of recreational cannabis. Citing robust evidence from other nations that have adopted legalisation, the Academy highlights significant...
Legal Battle Over Medical Marijuana Pharmacy in St. John Parish, Louisiana , US
Efforts to bring a medical marijuana pharmacy to St. John the Baptist Parish have sparked controversy, leading to a lawsuit over zoning disputes. Despite Louisiana legalising medical marijuana nearly a decade ago, local officials in this parish have blocked plans for a cannabis dispensary, citing zoning regulations. Permit Denial Sparks Lawsuit Omar Pecantte, owner of...
US Georgia Senate Advances Hemp Restrictions and THC Drink Ban
The Georgia Senate has advanced two significant bills aimed at tightening regulations on hemp-based products. The proposed measures include a total ban on THC-infused drinks and new limits on intoxicating compounds such as Delta-8 THC. These Georgia hemp product restrictions, still pending House approval, could shake up the market for many items currently found in...
Indiana Must Preserve Prior Authorization to Tackle Opioid Addiction
The opioid crisis has gripped communities across the United States, and Indiana is no exception. A significant factor often overlooked in this epidemic is the role of prescription opioids. What begins as medication for post-surgery pain relief can spiral into addiction, devastating lives and families. This is why safeguarding policies like prior authorization are crucial...
The Impact of Opioid Overdose Policy in British Columbia, Canada
Policies aimed at addressing opioid overdoses, such as implementing an opioid overdose policy through safer opioid supply and drug decriminalisation, are central to the ongoing debate on tackling this crisis. British Columbia stands as the first jurisdiction to introduce a province-wide safer supply initiative, followed by drug possession decriminalisation. While supporters argue these changes could...
Alabama’s Controversial Psychoactive Hemp Ban Proposal
Alabama is considering Senate Bill 132 (SB132), a proposed law aimed at enacting a Psychoactive Hemp Ban by reclassifying psychoactive cannabinoids as controlled substances. This move would eliminate the availability of non-industrial hemp products such as THC-infused beverages and federally compliant edibles. The aim, supporters contend, is to protect public health and prevent underage access...
US Senators Introduce Bill to Block $2.3 Billion Marijuana Industry Tax Break
A pivotal new bill (S.471) introduced by US Senators James Lankford (R-OK) and Pete Ricketts (R-NE) aims to curtail a $2.3 billion marijuana industry tax break by amending Section 280E of the federal tax code. The legislation, backed by Smart Approaches to Marijuana Action (SAM Action), seeks to ensure marijuana explicitly remains under the scope...
Study Highlights Lack of Evidence for Medical Marijuana Effectiveness
A recent study, featured in Mayo Clinic Proceedings: Innovations, Quality & Outcomes, casts doubt on the medical validity of marijuana by scrutinising the evidence supporting state-level qualifying conditions. Researchers compared these conditions with findings from a 2017 report by the National Academies of Sciences, Engineering, and Medicine (NASEM) on marijuana’s therapeutic potential. The NASEM report assessed...